αIIbβ3: structure and function-Reference-Cited by-同舟云学术

αIIbβ3: structure and function

Published:2015-06 Issue: Volume:13 Page:S17-S25
ISSN:1538-7933
Container-title:Journal of Thrombosis and Haemostasis
language:en
Short-container-title:J Thromb Haemost

Author:

Coller B. S.¹

Affiliation:

1. Rockefeller University; New York NY USA

Funder

National Heart, Lung, and Blood Institute

National Center for Advancing Translational Sciences

Stony Brook University

Publisher

Wiley

Subject

Hematology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/jth.12915/fullpdf

Reference66 articles.

1. The GPIIb/IIIa (integrin alphaIIbbeta3) odyssey: a technology-driven saga of a receptor with twists, turns, and even a bend;Coller;Blood,2008

2. Platelet glycoprotein IIb/IIIa blockers during percutaneous coronary intervention and as the initial medical treatment of non-ST segment elevation acute coronary syndromes;Bosch;Cochrane Database Syst Rev,2013

3. Neonatal alloimmune thrombocytopenia: pathogenesis, diagnosis and management;Peterson;Br J Haematol,2013

4. Structure of a complete integrin ectodomain in a physiologic resting state and activation and deactivation by applied forces;Zhu;Mol Cell,2008

5. Structural basis for allostery in integrins and binding to fibrinogen-mimetic therapeutics;Xiao;Nature,2004

Cited by 50 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. PCSK-9 inhibitors: a new direction for the future treatment of ischemic stroke;Frontiers in Pharmacology;2024-01-11

2. Anti-atherosclerotic effects and molecular targets of ginkgolide B from Ginkgo biloba;Acta Pharmaceutica Sinica B;2024-01

3. A Perspective on How Fibrinaloid Microclots and Platelet Pathology May be Applied in Clinical Investigations;Seminars in Thrombosis and Hemostasis;2023-09-25

4. Cryo-EM structures of full-length integrin αIIbβ3 in native lipids;Nature Communications;2023-07-13

5. A single F153Sβ3 mutation causes constitutive integrin αIIbβ3 activation in a variant form of Glanzmann thrombasthenia;Blood Advances;2023-07-03